Scientists have discovered a range of ‘biomarkers’ that could help to improve detection and treatment of gastrointestinal diseases (GIDs) such as gastric cancer (GC), colorectal cancer (CRC), and inflammatory bowel disease (IBD).
Researchers found that certain gut bacteria and metabolites are linked to each disease — suggesting that these biomarkers could help in early, less invasive diagnosis of GIDs, with some markers indicating risk across multiple diseases.
They used advanced machine…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply